Trial Profile
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare MICARDIS (Telmisartan) 80 mg Versus COZAAR (Losartan) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2023
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Telmisartan (Primary)
- Indications Diabetic nephropathies; Hypertension
- Focus Therapeutic Use
- Acronyms AMADEO
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 06 Mar 2008 Status changed from in progress to completed.
- 22 May 2007 Results data have been reported.
- 10 Nov 2005 New trial record.